NCT04893707 - The Study of CM310 in Patients With Atopic Dermatitis | Biotech Hunter

Enrollment

127

Participants

Timeline

Start Date

June 7, 2021

Primary Completion Date

February 3, 2023

Study Completion Date

February 3, 2023

Conditions

Moderate-to-severe Atopic Dermatitis

Interventions

BIOLOGICAL

CM310

"adults and teenagers (12 \~ 18 years) with weight ≥60 kg : 600mg for 1st dose, and then 300 mg, every 2 weeks and up to 1 year, SC.~teenagers (12 \~ 18 years) with weight ≥30 kg and \<60kg : 400mg for 1st dose, and then 200 mg, every 2 weeks and up to 1 year, SC."

Trial Locations (1)

Unknown

Peking University People's hospital, Beijing